Tech Company Financing Transactions
AbSci Funding Round
AbSci closed a $5.1 million Series A venture capital round on 4/26/2016. Backers included Phoenix Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
4/26/2016
Transaction Type
Venture Equity
Amount
$5,100,000
Round
Series A
Investors
Phoenix Venture Partners (Lead Investor) (Zach Jonasson)
Proceeds Purpose
Funding will accelerate commercialization of AbSci's SoluPro� protein expression platform for use in biopharmaceutical manufacturing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 E 6th St. 350
Vancouver, WA 98660
USA
Vancouver, WA 98660
USA
Phone
Website
Email Address
Overview
AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean McClain
Chief Financial Officer
Gregory Schiffman
Chief Operating Officer
Andrew Pihl
Chief Technical Officer
Matthew Weinstock
VP - General Counsel
Lawrence McClure
Browse more venture capital transactions:
Prev: 4/25/2016: Swyft venture capital transaction
Next: 4/26/2016: AkitaBox venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs